“菌”衡肝健康：微康益生菌临床循证引领护肝新路径

Core Insights - The 2025 China Nutrition and Health Autumn Market Summit focused on liver health, highlighting the "gut-liver axis" as a new target for disease prevention and intervention [1][3] Industry Trends - There is a significant increase in consumer awareness regarding liver health, with over 57% of Chinese consumers adjusting their lifestyles to protect their liver [3] - The market for liver health supplements has surpassed 2.4 billion yuan, indicating strong market demand [3] Scientific Developments - The "gut-liver axis" mechanism is becoming a focal point in liver health research, with interactions between the gut and liver affecting liver diseases [3][6] - Microbiome disruptions can lead to increased endotoxin levels and abnormal bile acid metabolism, contributing to conditions like non-alcoholic fatty liver disease and alcoholic liver disease [3] Company Innovations - Microbiome Probiotics has developed clinically validated probiotic strains, such as BC99, which significantly improve liver function indicators and reduce endotoxin levels [6] - The company utilizes an AI-driven strain development platform and has completed nearly 100 clinical trials across various health fields, establishing itself as a leader in clinical research and practice in probiotics [6] Market Positioning - With the shift in liver health demand from medical settings to daily health maintenance, probiotics are becoming a key choice for consumers in proactive health management [6][7] - Microbiome Probiotics aims to provide innovative and reliable solutions for liver health, positioning itself to capture a significant share of the growing health consumption market [7]